In line with this, it has been shown in several studies that endoglin can enhance TGF-β1-induced Smad1/5 and/or Smad2/3 phosphorylation in scleroderma fibroblasts, liver fibrosis, and cardiac fibrosis [27,48,50]. This evidence concerns the gene SMAD2 and scleroderma.